Current problems and future directions of transfusion-induced alloimmunization: Summary of an NHLBI working group

Transfusion

Volumn 51, Issue 2, 2011, Pages 435-441

  Zimring, James C ^a   Welniak, Lis ^a   Semple, John W ^a   Ness, Paul M ^a   Slichter, Sherrill J ^a   Spitalnik, Steven L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ARTICLE; AUTOIMMUNITY; BLOOD COMPONENT; CELLULAR IMMUNITY; CLINICAL RESEARCH; EPIGENETICS; ERYTHROCYTE; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; NONHUMAN; TECHNOLOGY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TRANSPLANTATION;

ADULT; ANIMALS; ANTIGENS, HUMAN PLATELET; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; COOPERATIVE BEHAVIOR; FEMALE; FORECASTING; HEALTH PRIORITIES; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; LYMPHOCYTE SUBSETS; MALE; MODELS, ANIMAL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PREGNANCY; RESEARCH PERSONNEL; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE; TRANSPLANTATION IMMUNOLOGY; UNITED STATES;

EID: 79951673833     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03024.x     Document Type: Article

References (23)

1. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB,. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-35.
2. Pasquini MC, Wang Z,. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides. 2010. [cited 2011 Jan 8]. Available from: URL
3. Whitaker BI, Green J, King MR, Leibeg LL, Mathew SM, Schlumpf KS, Schreiber GB,. The 2007 national blood collection and utilization survey. Washington, DC: Department of Health and Human Services; 2008.
4. Daniels G,. Human blood groups. 2nd ed. Oxford: Blackwell Science Ltd; 2002.
5. Reid ME, Lomas-Francis C,. The blood group antigen facts book. 2nd ed. Amsterdam: Elsevier; 2004.
6. Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood banking and transfusion medicine, basic principles and practice. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2007.
7. Roberts IA,. The changing face of haemolytic disease of the newborn. Early Hum Dev 2008; 84: 515-23.
8. Roback JD, Combs MR, Grossman BJ, HIllyer CD, editors. AABB technical manual. 16th ed. Bethesda, MD: AABB; 2008.
9. Arnold DM, Smith JW, Kelton JG,. Diagnosis and management of neonatal alloimmune thrombocytopenia. Transfus Med Rev 2008; 22: 255-67.
10. Heddle NM, Soutar RL, O'Hoski PL, Singer J, McBride JA, Ali MA, Kelton JG,. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000-5.
11. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA,. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119: 42-5.
12. Kiefel V, Konig C, Kroll H, Santoso S,. Platelet alloantibodies in transfused patients. Transfusion 2001; 41: 766-70. (Pubitemid 32538511)
13. Group TTTRATPS. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337: 1861-9.
14. Garratty G,. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997; 37: 357-61. (Pubitemid 27193547)
15. Hod EA, Arinsburg SA, Francis RO, Hendrickson JE, Zimring JC, Spitalnik SL,. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 2010; 99: 99-111.
16. Higgins JM, Sloan SR,. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112: 2546-53.
17. Tormey CA, Stack G,. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009; 114: 4279-82.
18. Tormey CA, Stack G,. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49: 505-12.
19. Ness PM,. To match or not to match: the questioin for chronically transfused patients with sickle cell anemia. Transfusion 1994; 34: 558-60.
20. Denomme GA, Flegel WA,. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008; 48: 2461-75.
21. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC,. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009; 114: 2315-22.
22. Patel SR, Cadwell CM, Medford A, Zimring JC,. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest 2009; 119: 2787-94.
23. Chow L, Aslam R, Speck ER, Kim M, Cridland N, Webster ML, Chen P, Sahib K, Ni H, Lazarus AH, Garvey MB, Freedman J, Semple JW,. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood 2010; 115: 1247-53.